PJ Quinn Inc.’s Post

When we asked 100 digital decision-makers from leading pharma orgs about the types of primary research they undertake in the context of their digital solutions, the top 3 responses were: 🗣️ 72% focus groups 💻 62% online feedback requests 📊 58% audience surveys Only 33% said they conduct one-to-one interviews with customers. This presents an opportunity for teams to gain a deeper level of customer insight and connection through one-to-one interviews and other qualitative research methods. This can be particularly key for patient-facing products and digital health initiatives, where we need to understand the full context of the patient experience to create successful, impactful interventions. Read more about this and uncover new sector insights in our Disconnected Pharma white paper: https://lnkd.in/eQyCzcEb #userresearch #customerinsight #digitalpharma

As a rule of thumb, pharma brands should follow three key steps to promote patient centricity: • get to know their audience inside out, • provide real value to them, • connect through the channels where their customers need them to be. But there are also a few things to implement on the organizational side of the company - I put those in the carousel, swipe. #patientcentricity #organizationalchange #patientcare

Just out - a new FirstWord Report: Redesigning digital health go-to-market models to align with drug commercialisation models, brought to you by FirstWord Group that FirstWord Pharma is also part of. It was a privilege to have been interviewed for this report and to have contributed my perspectives and learnings into this ongoing challenge to commercialize digital health. My view is that, on balance, #digitalhealth would benefit from having a different GTM model (or different models) and we should not force-fit the drug commercialization model. My various quotes on market segmentation, value demonstration, pricing & reimbursement, salesforce, external stakeholder engagement, post-launch surveillance, and challenges & solutions to a commercial redesign speaks to not a one-size-fits-all approach, being aligned to the intervention's intended use and delivering a unique value proposition that digital health interventions bring (and not a copy-and-paste from pharma). Thank you Dr Nicola Davies for the opportunity! https://lnkd.in/ePag-SXC #digitalhealth #digitalhealthcare #commercialization #gotomarket #digitalhealthevidence #perspective

Unveiling the power of semiotic analysis in global pharma market research. Unlock deeper insights into cultural nuances, patient behaviours, and brand perceptions across diverse markets. With semiotic analysis, we decode the symbols, signs, and meanings that drive physician and patient choices, paving the way for more effective communication strategies and successful global outreach. #elmaresearch #leadingwithideas #marketresearch #insight #semiotics

The shift towards digital media in pharma and med tech is undeniable. Manufacturers are increasingly investing in social media channels to reach physicians more effectively. MD Analytics interviewed 290 physicians to understand which channels they prefer for professional use. Share your thoughts! #pharma #medtech #digitalmedia https://ow.ly/EBAn50RetBe

The shift towards digital media in pharma and med tech is undeniable. Manufacturers are increasingly investing in social media channels to reach physicians more effectively. MD Analytics interviewed 290 physicians to understand which channels they prefer for professional use. Share your thoughts! #pharma #medtech #digitalmedia https://ow.ly/oAxV50RetBc

Complex therapies, shortened product life cycles, and fragmented and incomplete data sources are making it harder for #biopharma companies to identify and reach all relevant prescribers. Check out this new ebook to learn: - 6 challenges of legacy data offerings that lead to missed opportunities with HCPs - 2 ways to segment your data to prioritize HCPs and understand the key messages and channels that resonate with them - 4 steps to building a connected engagement strategy to reach more prescribers in niche markets Read it here: https://bit.ly/3SIneMf #lifesciences #VeevaCompass

The shift towards digital media in pharma and med tech is undeniable. Manufacturers are increasingly investing in social media channels to reach physicians more effectively. MD Analytics interviewed 290 physicians to understand which channels they prefer for professional use. Share your thoughts! #pharma #medtech #digitalmedia https://ow.ly/avpb50RetBj

The shift towards digital media in pharma and med tech is undeniable. Manufacturers are increasingly investing in social media channels to reach physicians more effectively. MD Analytics interviewed 290 physicians to understand which channels they prefer for professional use. Share your thoughts! #pharma #medtech #digitalmedia https://ow.ly/Q71a50RetBi